JJ

Jitto John

Active Director Director DIN 09123857
DIN 09123857 First appointment Mar 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Jitto John

Data last updated:

Jitto John is a Director at Zuvita Pharma Private Limited (since 2021). The company operates in Chemicals. Zuvita Pharma Private Limited reported revenue of ₹43.5 Lakh (FY 2025).

DIN 09123857
Primary Designation Director
Industry Chemicals
First Appointment 25 Mar 2021
Oldest Company Age 5 yrs
Largest company Zuvita Pharma Private Limited · ₹43.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zuvita Pharma Private Limited U24239KL2021PTC068296
Director25 Mar 20212021₹43.5 Lakh (FY 2025)Active

Board colleagues of Jitto John

NameDINCompanyDesignation
Aby Kuriachen09123856Zuvita Pharma Private LimitedDirector
Bibi Kuriachan06823043Zuvita Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zuvita Pharma Private Limited
Premium access

Shareholding and investment profile for Jitto John

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitto John

Jitto John currently holds 1 directorship: Zuvita Pharma Private Limited (Director, since 25 Mar 2021, revenue ₹43.5 Lakh (FY 2025)).

Jitto John was first appointed on 25 Mar 2021 as Director at Zuvita Pharma Private Limited.

The current boards of Jitto John's companies include Aby Kuriachen (Zuvita Pharma Private Limited), Bibi Kuriachan (Zuvita Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available